Смотреть видео онлайн

Dr. Brose on Vandetanib for Differentiated Thyroid Cancer

   
- HD качество

В базе 44 видео
Dr. Brose on Vandetanib for Differentiated Thyroid Cancer
Загружен 5 февраля 2014
Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, ...

Dr. Brose Discusses Lenvatinib for the Treatment of Patients With Thyroid Cancer
Загружен 2 сентября 2015
Marcia S. Brose, MD, PhD, associate professor of Otorhinolaryngology, Head and Neck Surgery at the Hospital of the University of Pennsylvania, discusses the ...

Dr. Marcia Brose Describes Sorafenib in RAI-Resistant Differentiated Thyroid Cancer
Загружен 14 июня 2013
Marcia Brose, MD, PhD, an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Dr. Marcia Brose on Sorafenib in Radioactive Iodine-Resistant Thyroid Cancer
Загружен 3 июня 2013
Marcia Brose, MD, PhD, and an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Prof. L. Wirth - Advanced differentiated thyroid cancer
Загружен 26 ноября 2015
Listen to the Italian translation here: https://youtu.be/EqxxhfnzwK8 Find out more about ITCO Foundation here:

Vandetanib improves PFS in thyroid cancer
Загружен 6 ноября 2014
Visit (Hospital Universitario Ramón y Cajal, Madrid, Spain) talks to ecancertv at ESMO 2014 about his work looking ...

Dr. Langmuir on the Advantages of Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on the Advantages of Vandetanib in Medullary Thyroid Cancer.

Dr. Langmuir on Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on Vandetanib in Medullary Thyroid Cancer.

Sorafenib Extends Survival in Differentiated Thyroid Cancer
Загружен 3 июня 2013
A new trial has found that sorafenib may help extend the survival of patients with differentiated thyroid cancer. In the phase-III DECISION trial, progression-free ...

Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance
Загружен 24 мая 2011
In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert ...

Targeted therapy for iodine-refractory thyroid cancer
Загружен 6 ноября 2014
Visit (National Cancer Center Hospital East, Kashiwa, Japan) talks to ecancertv at ESMO 2014 about the ...

New Hope for Patients with Thyroid Cancer: Spotlight on Marcia Brose, MD, PhD
Загружен 6 сентября 2013
New Hope for Patients with Thyroid Cancer: Spotlight on Marcia Brose, MD, PhD.

Dr. Brose Discusses The Tolerability of Sorafenib in Thyroid Cancer
Загружен 9 июля 2014
Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, ...

Combination of pazopanib and paclitaxel safe in urothelial cancer
Загружен 6 мая 2015
Prof Sandy Srinivas, (Stanford University Medical Centre, Stanford, USA) talks to ecancertv at ASCO GU 2015 about the results of a phase II study which looked ...

Dr. Langmuir Explains the Side Effects of Vandetanib
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca Explains the Side Effects of Vandetanib.

 1 2 3 » 

Мир в онлайне